Back to Articles
GeneralBusiness Today

RPG Life Sciences to launch GLP-1 drug in October after ₹215 crore API acquisitions

The GLP-1 push comes as RPG Life Sciences is also rapidly expanding its API business.

Attribution

This digest is published with acknowledgment to Business Today. For the complete analysis, headnotes, and citations, please refer to the source.

Read on Business Today

More Articles